国际皮肤性病学杂志    2006 32 (3): 191-193   ISSN: 2096-5540  CN: 32-1880/R   黑素瘤与MAPK信号途径 韩永智, 孙建方 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2005-10-08  修回日期 null  网络版发布日期 null 参考文献  [1] Cowan K J,Storey KB.Mitogen-activated protein kinases:new signaling pathways functioning in cellular responses to environmental stress.J Exp Biol,2003,206(Pt 7):1107-1115. [2] Choi KC,Auersperg N,Leung PC.Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium.Reprod Biol Endocrinol,2003,1:71. [3] Davies H,Bignell GR,Cox C,et al.Mutations of the BRAF gene in human cancer.Nature,2002,417:949-954. [4] Wellbrock C,Ogilvie L,Hedley D,et al.V599EB-RAF is an oncogene in melanocytes.Cancer Res,2004,64:2338-2342. [5] Sumimoto H,Miyagishi M,Miyoshi H,et al.Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.Oncogene,2004,23:6031-6039. [6] Goodall J,Wellbrock C,Dexter TJ,et al.The Brn-2 transcription factor links activated BRAF to melanoma proliferation.Mol Cell Biol,2004,24:2923-2931. [7] Bhatt KV,Spofford LS,Aram G,et al.Adhesion control of cyclin D1 and p27Kipl levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.Oncogene,2005,24:3459-3471. [8] Tsavachidou D,Coleman ML,Athanasiadis G,et al.SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.Cancer Res,2004,64:5556-5559. [9] Yazdi AS,Palmedo G,Flaig MJ,et al.Mutations of the BRAF gene in benign and malignant melanocytic lesions.J Invest Dermatol,2003,121:1160-1162. [10] Loewe R,Kittler H,Fischer G,et al.BRAF kinase gene V599E mutation in growing melanocytic lesions.J Invest Dermatol,2004,123:733-736. [11] Dong J,Phelps RG,Qiao R,et al.BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.Cancer Res,2003,63:3883-3885. [12] Garraway LA,Widlund HR,Rubin MA,et al.Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.Nature,2005,436:117-122. [13] Patton EE,Widlund HR,Kutok JL,et al.BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.Curr Biol,2005,15:249-254. [14] Maldonado JL,Fridlyand J,Patel H,et al.Determinants of BRAF mutations in primary melanomas.J Natl Cancer Inst,2003,95:1878-1890. [15] Sasaki Y,Niu C,Makino R,et al.BRAF point mutations in primary melanoma show different prevalences by subtype.J Invest Dermatol,2004,123:177-183. [16] Chang DZ,Panageas KS,Osman I,et al.Clinical significance of BRAF mutations in metastatic melanoma.J Transl Med,2004,2:46. [17] Shinozaki M,Fujimoto A,Morton DL,et al.Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.Clin Cancer Res,2004,10:1753-1757. [18] Houben R,Becker JC,Kappel A,et al.Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis.J Carcinog,2004,26,3:6. [19] Kumar R,Angelini S,Czene K,et al.BRAF mutations in metastatic melanoma:a possible association with clinical outcome.Clin Cancer Res,2003,9:3362-3368. [20] Sharma A,Trivedi NR,Zimmerman MA,et al.Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.Cancer Res,2005,65:2412-2421. [21] Huntington JT,Shields JM,Der CJ,et al.Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells:role of BRAF mutation and fibroblast growth factor signaling.J Biol Chem,2004,279:33168-33176. [22] Meyer P,Klaes R,Schmitt C,et al.Exclusion of BRAFV599E as a melanoma susceptibility mutation.Int J Cancer,2003,106:78. [23] Reifenberger J,Knobbe CB,Sterzinger AA,et al.Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.Int J Cancer,2004,109:377-384. [24] Cruz F 3rd,Rubin BP,Wilson D,et al.Absence of BRAF and NRAS mutations in uveal melanoma.Cancer Res,2003,63:5761. [25] Adjei AA.Blocking oncogenic Ras signaling for cancer therapy.J Natl Cancer Inst,2001,93:1062-1074. [26] Eskandarpour M,Kiaii S,Zhu C,et al.Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells.Int J Cancer.,2005,115:65-73. [27] Smalley KS.A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer,2003,104:527-532. [28] Zuidervaart W,van Nieuwpoort F,Stark M,et al.Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.Br J Cancer,2005,92:2032-2038. 通讯作者: